July 11, 2019
Nordic Nanovector completes patient enrolment into Phase 1 trial of Betalutin® in diffuse large B-cell lymphoma (DLBCL)
Media
July 11, 2019
Orexo Interim Report Q2 2019
July 10, 2019
Altimmune Signs Definitive Agreement to Acquire Spitfire Pharma, Inc. Adding NASH Drug Candidate to Portfolio
July 10, 2019
Orexo prepays part of the corporate bond loan
July 10, 2019
MIPS APPOINTS NEW CFO
July 09, 2019
Targovax announces encouraging results from part 1 of the ONCOS-102 and Keytruda combination trial in anti-PD1 refractory melanoma
July 01, 2019
Strongbridge Biopharma plc Added to the Russell 3000® and Microcap® Indexes
June 28, 2019
Oncopeptides has completed a directed share issue of approximately SEK 727 million
June 25, 2019
MIPS ACQUIRES THE BRAND GLIDEWEAR AND THE ASSOCIATED PATENT RIGHTS
June 24, 2019
Karo Pharma acquires Trimb for MSEK 3,400
